Erik Digman Wiklund appointed new CEO of Targovax ASA
OSLO, NORWAY: Targovax ASA announced the appointment of Dr. Erik Digman Wiklund as Chief Executive Officer (CEO). Dr. Wiklund has intimate knowledge of the company...
Targovax ASA
Targovax ASA (OSE:TRVX) is a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors. Targovax aims to unlock greater clinical benefits in...